Annovis Bio CEO Participates in Roundtable Discussion

Annovis Bio

BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS) announced its Founder and Chief Executive Officer, Maria Maccecchini, Ph.D., will participate in the Financial Times’ Outstanding Director Exchange (ODX) Roundtable: The Evolving Relationship Between Pharma and Biotech on Tuesday, October 20, 2020 at 11:40 a.m. ET.

The ODX conference is now in its 16th year and continues to be the gold standard for director education and community. Attendance is limited exclusively to sitting public company directors.

In addition, Dr. Maccecchini will participate in the Angel Venture Fair Women’s Founders and Funders panel discussion on October 20, 2020 at 8:15 a.m. ET. Angel Venture Fair, a non-profit consortium of accredited investors and angel investor groups, brings together the largest gathering of angel, seed, and early-stage investors in the Mid-Atlantic region.

READ:  Annovis Bio to Participate in A.G.P.'s Virtual Healthcare Symposium

“I am excited to share my experiences on both of these subjects with the director community and with aspiring women entrepreneurs,” continued Dr. Maccecchini. “I have been working with small companies as a CEO, director and angel investor since 1992. With deep experience as an investor and entrepreneur, I believe I can provide valuable insight that attendees at both events can apply on their paths to success.”

Headquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Alzheimer’s in Down Syndrome (AD-DS).

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee